{"entity":{"type":"insider","cik":"0001650527","url":"/insider/0001650527","json_url":"/insider/0001650527.json","name":"Green Jeremy","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":103,"n_filings":46,"first":"2015-08-10","last":"2026-08-07","span_basis":"filed_date"},"name_variants":[{"name":"Green Jeremy","source":"filing","n_filings":46,"first_seen":"2015-08-10","last_seen":"2026-08-07"}],"transactions":[{"id":6071506,"accession":"0001104659-26-092867","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-26-092867","line_url":"/filing/0001104659-26-092867","is_derivative":false,"issuer_cik":"0001425738","issuer_name":"Attovia Therapeutics, Inc.","issuer_ticker":"ATTO","issuer_name_source":null,"issuer_url":"/issuer/0001425738","owner_cik":null,"owner_name":"Redmile Group, LLC; Redmile Biopharma Investments III, L.P.; Green Jeremy","owner_display_name":"Redmile Group, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":600000.0,"shares_display":"600,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":10200000.0,"total_display":"10,200,000.00","total_whole":"10,200,000","shares_owned_after":1182854.0,"shares_owned_after_display":"1,182,854","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-06","filed_date":"2026-08-07","scope":"insider","n_lines":2},{"id":6150956,"accession":"0001104659-26-039359","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001104659-26-039359","line_url":"/filing/0001104659-26-039359","is_derivative":false,"issuer_cik":"0001425738","issuer_name":"ADC Therapeutics SA","issuer_ticker":"ADCT","issuer_name_source":null,"issuer_url":"/issuer/0001425738","owner_cik":null,"owner_name":"RedCo II Master Fund, L.P.; Green Jeremy; Redmile Group, LLC","owner_display_name":"RedCo II Master Fund, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5163997.0,"shares_display":"5,163,997","price_per_share":3.279,"price_display":"3.28","price_state":"stated","total_value":16932746.163,"total_display":"16,932,746.16","total_whole":"16,932,746","shares_owned_after":12666731.0,"shares_owned_after_display":"12,666,731","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-02","filed_date":"2026-04-02","scope":"insider","n_lines":2},{"id":6150950,"accession":"0001104659-26-039359","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-26-039359","line_url":"/filing/0001104659-26-039359","is_derivative":false,"issuer_cik":"0001425738","issuer_name":"ADC Therapeutics SA","issuer_ticker":"ADCT","issuer_name_source":null,"issuer_url":"/issuer/0001425738","owner_cik":null,"owner_name":"RedCo II Master Fund, L.P.; Green Jeremy; Redmile Group, LLC","owner_display_name":"RedCo II Master Fund, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":331782.0,"shares_display":"331,782","price_per_share":3.799,"price_display":"3.80","price_state":"stated","total_value":1260439.818,"total_display":"1,260,439.82","total_whole":"1,260,440","shares_owned_after":15301237.0,"shares_owned_after_display":"15,301,237","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-01","filed_date":"2026-04-02","scope":"insider","n_lines":2},{"id":6150944,"accession":"0001104659-26-039359","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-26-039359","line_url":"/filing/0001104659-26-039359","is_derivative":false,"issuer_cik":"0001425738","issuer_name":"ADC Therapeutics SA","issuer_ticker":"ADCT","issuer_name_source":null,"issuer_url":"/issuer/0001425738","owner_cik":null,"owner_name":"RedCo II Master Fund, L.P.; Green Jeremy; Redmile Group, LLC","owner_display_name":"RedCo II Master Fund, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":384636.0,"shares_display":"384,636","price_per_share":3.752,"price_display":"3.75","price_state":"stated","total_value":1443154.272,"total_display":"1,443,154.27","total_whole":"1,443,154","shares_owned_after":15470502.0,"shares_owned_after_display":"15,470,502","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-03-31","filed_date":"2026-04-02","scope":"insider","n_lines":2},{"id":2998746,"accession":"0001104659-24-131794","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-24-131794","line_url":"/filing/0001104659-24-131794#line-4","is_derivative":false,"issuer_cik":"0001425738","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001425738","owner_cik":null,"owner_name":"Redmile Group, LLC; Green Jeremy","owner_display_name":"Redmile Group, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":341633.0,"shares_display":"341,633","price_per_share":1.68,"price_display":"1.68","price_state":"stated","total_value":573943.44,"total_display":"573,943.44","total_whole":"573,943","shares_owned_after":12486313.0,"shares_owned_after_display":"12,486,313","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-20","filed_date":"2024-12-26","scope":"insider"},{"id":2998744,"accession":"0001104659-24-131794","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-24-131794","line_url":"/filing/0001104659-24-131794#line-3","is_derivative":false,"issuer_cik":"0001425738","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001425738","owner_cik":null,"owner_name":"Redmile Group, LLC; Green Jeremy","owner_display_name":"Redmile Group, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":397964.0,"shares_display":"397,964","price_per_share":1.68,"price_display":"1.68","price_state":"stated","total_value":668579.52,"total_display":"668,579.52","total_whole":"668,580","shares_owned_after":12884277.0,"shares_owned_after_display":"12,884,277","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-20","filed_date":"2024-12-26","scope":"insider"},{"id":2964386,"accession":"0001104659-24-128575","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-24-128575","line_url":"/filing/0001104659-24-128575","is_derivative":false,"issuer_cik":"0001425738","issuer_name":"ADC Therapeutics SA","issuer_ticker":"ADCT","issuer_name_source":null,"issuer_url":"/issuer/0001425738","owner_cik":null,"owner_name":"RedCo II Master Fund, L.P.; Green Jeremy; Redmile Group, LLC","owner_display_name":"RedCo II Master Fund, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Shares, par value CHF 0.08 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":3.045,"price_display":"3.04","price_state":"stated","total_value":609000.0,"total_display":"609,000.00","total_whole":"609,000","shares_owned_after":15666731.0,"shares_owned_after_display":"15,666,731","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-11","filed_date":"2024-12-13","scope":"insider","n_lines":4},{"id":2462277,"accession":"0001104659-24-126421","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-24-126421","line_url":"/filing/0001104659-24-126421#line-4","is_derivative":false,"issuer_cik":"0001425738","issuer_name":"Shattuck Labs, Inc.","issuer_ticker":"STTK","issuer_name_source":null,"issuer_url":"/issuer/0001425738","owner_cik":null,"owner_name":"Redmile Group, LLC; Green Jeremy","owner_display_name":"Redmile Group, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":133371.0,"shares_display":"133,371","price_per_share":1.25,"price_display":"1.25","price_state":"stated","total_value":166713.75,"total_display":"166,713.75","total_whole":"166,714","shares_owned_after":5406353.0,"shares_owned_after_display":"5,406,353","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-04","filed_date":"2024-12-06","scope":"insider"},{"id":2462273,"accession":"0001104659-24-126421","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-24-126421","line_url":"/filing/0001104659-24-126421#line-3","is_derivative":false,"issuer_cik":"0001425738","issuer_name":"Shattuck Labs, Inc.","issuer_ticker":"STTK","issuer_name_source":null,"issuer_url":"/issuer/0001425738","owner_cik":null,"owner_name":"Redmile Group, LLC; Green Jeremy","owner_display_name":"Redmile Group, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":133371.0,"shares_display":"133,371","price_per_share":1.25,"price_display":"1.25","price_state":"stated","total_value":166713.75,"total_display":"166,713.75","total_whole":"166,714","shares_owned_after":5539724.0,"shares_owned_after_display":"5,539,724","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-04","filed_date":"2024-12-06","scope":"insider"},{"id":2306272,"accession":"0001104659-24-126422","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-24-126422","line_url":"/filing/0001104659-24-126422#line-4","is_derivative":false,"issuer_cik":"0001425738","issuer_name":"ADC Therapeutics SA","issuer_ticker":"ADCT","issuer_name_source":null,"issuer_url":"/issuer/0001425738","owner_cik":null,"owner_name":"RedCo II Master Fund, L.P.; Green Jeremy; Redmile Group, LLC","owner_display_name":"RedCo II Master Fund, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Shares, par value CHF 0.08 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25352.0,"shares_display":"25,352","price_per_share":2.07,"price_display":"2.07","price_state":"stated","total_value":52478.64,"total_display":"52,478.64","total_whole":"52,479","shares_owned_after":15566731.0,"shares_owned_after_display":"15,566,731","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-04","filed_date":"2024-12-06","scope":"insider"},{"id":2043293,"accession":"0001104659-24-077865","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-077865","line_url":"/filing/0001104659-24-077865","is_derivative":false,"issuer_cik":"0001425738","issuer_name":"ADC Therapeutics SA","issuer_ticker":"ADCT","issuer_name_source":null,"issuer_url":"/issuer/0001425738","owner_cik":null,"owner_name":"RedCo II Master Fund, L.P.; Redmile Group, LLC; Green Jeremy","owner_display_name":"RedCo II Master Fund, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Shares, par value CHF 0.08 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800000.0,"shares_display":"800,000","price_per_share":2.81,"price_display":"2.81","price_state":"stated","total_value":2248000.0,"total_display":"2,248,000.00","total_whole":"2,248,000","shares_owned_after":15669217.0,"shares_owned_after_display":"15,669,217","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-01","filed_date":"2024-07-03","scope":"insider","n_lines":2},{"id":3232115,"accession":"0001104659-24-031215","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-031215","line_url":"/filing/0001104659-24-031215#line-1","is_derivative":false,"issuer_cik":"0001425738","issuer_name":"Absci Corp","issuer_ticker":"ABSI","issuer_name_source":null,"issuer_url":"/issuer/0001425738","owner_cik":null,"owner_name":"Green Jeremy; Redmile Group, LLC","owner_display_name":"Green Jeremy","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":222222.0,"shares_display":"222,222","price_per_share":4.5,"price_display":"4.50","price_state":"stated","total_value":999999.0,"total_display":"999,999.00","total_whole":"999,999","shares_owned_after":8253316.0,"shares_owned_after_display":"8,253,316","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-03-01","filed_date":"2024-03-05","scope":"insider"},{"id":8357787,"accession":"0001104659-23-130203","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-23-130203","line_url":"/filing/0001104659-23-130203#line-3","is_derivative":false,"issuer_cik":"0001425738","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001425738","owner_cik":null,"owner_name":"Redmile Group, LLC; Green Jeremy","owner_display_name":"Redmile Group, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":44630.0,"shares_display":"44,630","price_per_share":3.72,"price_display":"3.72","price_state":"stated","total_value":166023.6,"total_display":"166,023.60","total_whole":"166,024","shares_owned_after":13180388.0,"shares_owned_after_display":"13,180,388","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-26","filed_date":"2023-12-28","scope":"insider"},{"id":8225144,"accession":"0001104659-23-120752","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-120752","line_url":"/filing/0001104659-23-120752","is_derivative":false,"issuer_cik":"0001425738","issuer_name":"Augmedix, Inc.","issuer_ticker":"AUGX","issuer_name_source":null,"issuer_url":"/issuer/0001425738","owner_cik":null,"owner_name":"Redmile Group, LLC; Green Jeremy; RedCo II Master Fund, L.P.","owner_display_name":"Redmile Group, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500000.0,"shares_display":"1,500,000","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":6000000.0,"total_display":"6,000,000.00","total_whole":"6,000,000","shares_owned_after":16404017.0,"shares_owned_after_display":"16,404,017","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-20","filed_date":"2023-11-22","scope":"insider","n_lines":2},{"id":7944566,"accession":"0001104659-23-077730","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-23-077730","line_url":"/filing/0001104659-23-077730#line-4","is_derivative":false,"issuer_cik":"0001425738","issuer_name":"IGM Biosciences, Inc.","issuer_ticker":"IGMS","issuer_name_source":null,"issuer_url":"/issuer/0001425738","owner_cik":null,"owner_name":"Green Jeremy; Redmile Group, LLC","owner_display_name":"Green Jeremy","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80423.0,"shares_display":"80,423","price_per_share":9.42,"price_display":"9.42","price_state":"stated","total_value":757584.66,"total_display":"757,584.66","total_whole":"757,585","shares_owned_after":2893763.0,"shares_owned_after_display":"2,893,763","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-29","filed_date":"2023-07-03","scope":"insider"},{"id":7944563,"accession":"0001104659-23-077730","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-23-077730","line_url":"/filing/0001104659-23-077730#line-3","is_derivative":false,"issuer_cik":"0001425738","issuer_name":"IGM Biosciences, Inc.","issuer_ticker":"IGMS","issuer_name_source":null,"issuer_url":"/issuer/0001425738","owner_cik":null,"owner_name":"Green Jeremy; Redmile Group, LLC","owner_display_name":"Green Jeremy","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":80423.0,"shares_display":"80,423","price_per_share":9.42,"price_display":"9.42","price_state":"stated","total_value":757584.66,"total_display":"757,584.66","total_whole":"757,585","shares_owned_after":2974186.0,"shares_owned_after_display":"2,974,186","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-29","filed_date":"2023-07-03","scope":"insider"},{"id":8622804,"accession":"0001104659-23-048557","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-048557","line_url":"/filing/0001104659-23-048557#line-2","is_derivative":false,"issuer_cik":"0001425738","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001425738","owner_cik":null,"owner_name":"Green Jeremy; Redmile Group, LLC","owner_display_name":"Green Jeremy","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":256639.0,"shares_display":"256,639","price_per_share":6.18,"price_display":"6.18","price_state":"stated","total_value":1586029.02,"total_display":"1,586,029.02","total_whole":"1,586,029","shares_owned_after":13135758.0,"shares_owned_after_display":"13,135,758","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-04-21","filed_date":"2023-04-21","scope":"insider"},{"id":8622801,"accession":"0001104659-23-048557","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-048557","line_url":"/filing/0001104659-23-048557#line-1","is_derivative":false,"issuer_cik":"0001425738","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001425738","owner_cik":null,"owner_name":"Green Jeremy; Redmile Group, LLC","owner_display_name":"Green Jeremy","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":5.99,"price_display":"5.99","price_state":"stated","total_value":119800.0,"total_display":"119,800.00","total_whole":"119,800","shares_owned_after":12879119.0,"shares_owned_after_display":"12,879,119","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-04-20","filed_date":"2023-04-21","scope":"insider"},{"id":8118787,"accession":"0001104659-23-046353","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-23-046353","line_url":"/filing/0001104659-23-046353#line-5","is_derivative":false,"issuer_cik":"0001425738","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001425738","owner_cik":null,"owner_name":"Redmile Group, LLC; Green Jeremy","owner_display_name":"Redmile Group, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":302339.0,"shares_display":"302,339","price_per_share":5.84,"price_display":"5.84","price_state":"stated","total_value":1765659.76,"total_display":"1,765,659.76","total_whole":"1,765,660","shares_owned_after":12833419.0,"shares_owned_after_display":"12,833,419","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-04-14","filed_date":"2023-04-17","scope":"insider"},{"id":8118783,"accession":"0001104659-23-046353","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-23-046353","line_url":"/filing/0001104659-23-046353#line-4","is_derivative":false,"issuer_cik":"0001425738","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001425738","owner_cik":null,"owner_name":"Redmile Group, LLC; Green Jeremy","owner_display_name":"Redmile Group, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25700.0,"shares_display":"25,700","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":154200.0,"total_display":"154,200.00","total_whole":"154,200","shares_owned_after":12859119.0,"shares_owned_after_display":"12,859,119","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-04-14","filed_date":"2023-04-17","scope":"insider"},{"id":9223757,"accession":"0001104659-22-109481","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-109481","line_url":"/filing/0001104659-22-109481#line-1","is_derivative":false,"issuer_cik":"0001425738","issuer_name":"Zymeworks Inc.","issuer_ticker":"ZYME","issuer_name_source":null,"issuer_url":"/issuer/0001425738","owner_cik":null,"owner_name":"Green Jeremy; Redmile Group, LLC","owner_display_name":"Green Jeremy","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, par value $0.00001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30481.0,"shares_display":"30,481","price_per_share":5.0338,"price_display":"5.03","price_state":"stated","total_value":153435.2578,"total_display":"153,435.26","total_whole":"153,435","shares_owned_after":6075918.0,"shares_owned_after_display":"6,075,918","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-13","filed_date":"2022-10-18","scope":"insider"},{"id":5536524,"accession":"0001104659-21-134623","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-134623","line_url":"/filing/0001104659-21-134623#line-2","is_derivative":false,"issuer_cik":"0001425738","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001425738","owner_cik":null,"owner_name":"Redmile Biopharma Investments III, L.P.; Green Jeremy; Redmile Group, LLC","owner_display_name":"Redmile Biopharma Investments III, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000000.0,"shares_display":"1,000,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":20000000.0,"total_display":"20,000,000.00","total_whole":"20,000,000","shares_owned_after":1954420.0,"shares_owned_after_display":"1,954,420","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-02","filed_date":"2021-11-04","scope":"insider"},{"id":9223804,"accession":"0001104659-23-048555","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-048555","line_url":"/filing/0001104659-23-048555#line-1","is_derivative":false,"issuer_cik":"0001425738","issuer_name":"Augmedix, Inc.","issuer_ticker":"AUGX","issuer_name_source":null,"issuer_url":"/issuer/0001425738","owner_cik":null,"owner_name":"Green Jeremy; Redmile Group, LLC; Redmile Private Investments II, L.P.","owner_display_name":"Green Jeremy","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1625000.0,"shares_display":"1,625,000","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":6500000.0,"total_display":"6,500,000.00","total_whole":"6,500,000","shares_owned_after":6218238.0,"shares_owned_after_display":"6,218,238","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-28","filed_date":"2023-04-21","scope":"insider"},{"id":4130689,"accession":"0001104659-21-132515","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-132515","line_url":"/filing/0001104659-21-132515#line-1","is_derivative":false,"issuer_cik":"0001425738","issuer_name":"Augmedix, Inc.","issuer_ticker":"AUGX","issuer_name_source":null,"issuer_url":"/issuer/0001425738","owner_cik":null,"owner_name":"Redmile Group, LLC; Green Jeremy","owner_display_name":"Redmile Group, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1625000.0,"shares_display":"1,625,000","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":6500000.0,"total_display":"6,500,000.00","total_whole":"6,500,000","shares_owned_after":14380327.0,"shares_owned_after_display":"14,380,327","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-28","filed_date":"2021-11-01","scope":"insider"},{"id":5206620,"accession":"0001104659-21-104447","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-104447","line_url":"/filing/0001104659-21-104447#line-2","is_derivative":false,"issuer_cik":"0001425738","issuer_name":"Adagio Therapeutics, Inc.","issuer_ticker":"ADGI","issuer_name_source":null,"issuer_url":"/issuer/0001425738","owner_cik":null,"owner_name":"Green Jeremy; Redmile Group, LLC","owner_display_name":"Green Jeremy","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1470000.0,"shares_display":"1,470,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":24990000.0,"total_display":"24,990,000.00","total_whole":"24,990,000","shares_owned_after":3390960.0,"shares_owned_after_display":"3,390,960","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-10","filed_date":"2021-08-12","scope":"insider"},{"id":4365881,"accession":"0001104659-21-097155","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-21-097155","line_url":"/filing/0001104659-21-097155#line-3","is_derivative":false,"issuer_cik":"0001425738","issuer_name":"Absci Corp","issuer_ticker":"ABSI","issuer_name_source":null,"issuer_url":"/issuer/0001425738","owner_cik":null,"owner_name":"Green Jeremy; Redmile Group, LLC","owner_display_name":"Green Jeremy","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1875000.0,"shares_display":"1,875,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":30000000.0,"total_display":"30,000,000.00","total_whole":"30,000,000","shares_owned_after":8031094.0,"shares_owned_after_display":"8,031,094","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-26","filed_date":"2021-07-28","scope":"insider"},{"id":4673141,"accession":"0001104659-21-084633","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-084633","line_url":"/filing/0001104659-21-084633#line-2","is_derivative":false,"issuer_cik":"0001425738","issuer_name":"Verve Therapeutics, Inc.","issuer_ticker":"VERV","issuer_name_source":null,"issuer_url":"/issuer/0001425738","owner_cik":null,"owner_name":"Redmile Group, LLC; Green Jeremy","owner_display_name":"Redmile Group, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1050000.0,"shares_display":"1,050,000","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":19950000.0,"total_display":"19,950,000.00","total_whole":"19,950,000","shares_owned_after":1936530.0,"shares_owned_after_display":"1,936,530","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-21","filed_date":"2021-06-23","scope":"insider"},{"id":5096317,"accession":"0001104659-21-003446","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-003446","line_url":"/filing/0001104659-21-003446#line-1","is_derivative":false,"issuer_cik":"0001425738","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001425738","owner_cik":null,"owner_name":"Redmile Group, LLC; Green Jeremy","owner_display_name":"Redmile Group, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":327485.0,"shares_display":"327,485","price_per_share":85.5,"price_display":"85.50","price_state":"stated","total_value":27999967.5,"total_display":"27,999,967.50","total_whole":"27,999,968","shares_owned_after":12957222.0,"shares_owned_after_display":"12,957,222","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-08","filed_date":"2021-01-12","scope":"insider"},{"id":5205876,"accession":"0001104659-21-023991","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-023991","line_url":"/filing/0001104659-21-023991","is_derivative":false,"issuer_cik":"0001425738","issuer_name":"Aprea Therapeutics, Inc.","issuer_ticker":"APRE","issuer_name_source":null,"issuer_url":"/issuer/0001425738","owner_cik":null,"owner_name":"Redmile Group, LLC; Green Jeremy","owner_display_name":"Redmile Group, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500000.0,"shares_display":"500,000","price_per_share":5.58257972,"price_display":"5.58","price_state":"stated","total_value":2791289.86,"total_display":"2,791,289.86","total_whole":"2,791,290","shares_owned_after":1774581.0,"shares_owned_after_display":"1,774,581","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-28","filed_date":"2021-02-16","scope":"insider","n_lines":2},{"id":2340274,"accession":"0001104659-20-115357","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001104659-20-115357","line_url":"/filing/0001104659-20-115357","is_derivative":false,"issuer_cik":"0001425738","issuer_name":"Shattuck Labs, Inc.","issuer_ticker":"STTK","issuer_name_source":null,"issuer_url":"/issuer/0001425738","owner_cik":null,"owner_name":"Redmile Group, LLC; Green Jeremy","owner_display_name":"Redmile Group, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3441176.0,"shares_display":"3,441,176","price_per_share":17.33981133513659,"price_display":"17.34","price_state":"stated","total_value":59669342.611,"total_display":"59,669,342.61","total_whole":"59,669,343","shares_owned_after":5119914.0,"shares_owned_after_display":"5,119,914","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-10-14","filed_date":"2020-10-15","scope":"insider","n_lines":6},{"id":2467417,"accession":"0001104659-20-113147","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-113147","line_url":"/filing/0001104659-20-113147#line-1","is_derivative":false,"issuer_cik":"0001425738","issuer_name":"Augmedix, Inc.","issuer_ticker":"AUGX","issuer_name_source":null,"issuer_url":"/issuer/0001425738","owner_cik":null,"owner_name":"Redmile Group, LLC; Green Jeremy","owner_display_name":"Redmile Group, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000000.0,"shares_display":"5,000,000","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":15000000.0,"total_display":"15,000,000.00","total_whole":"15,000,000","shares_owned_after":12755327.0,"shares_owned_after_display":"12,755,327","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-10-05","filed_date":"2020-10-07","scope":"insider"},{"id":2611746,"accession":"0001104659-20-103551","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-20-103551","line_url":"/filing/0001104659-20-103551","is_derivative":false,"issuer_cik":"0001425738","issuer_name":"IGM Biosciences, Inc.","issuer_ticker":"IGMS","issuer_name_source":null,"issuer_url":"/issuer/0001425738","owner_cik":null,"owner_name":"Green Jeremy; Redmile Group, LLC","owner_display_name":"Green Jeremy","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":23260.0,"shares_display":"23,260","price_per_share":52.55092884780739,"price_display":"52.55","price_state":"stated","total_value":1222334.605,"total_display":"1,222,334.60","total_whole":"1,222,335","shares_owned_after":3417161.0,"shares_owned_after_display":"3,417,161","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-09","filed_date":"2020-09-09","scope":"insider","n_lines":2},{"id":2611737,"accession":"0001104659-20-103551","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-103551","line_url":"/filing/0001104659-20-103551#line-2","is_derivative":false,"issuer_cik":"0001425738","issuer_name":"IGM Biosciences, Inc.","issuer_ticker":"IGMS","issuer_name_source":null,"issuer_url":"/issuer/0001425738","owner_cik":null,"owner_name":"Green Jeremy; Redmile Group, LLC","owner_display_name":"Green Jeremy","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":47113.0,"shares_display":"47,113","price_per_share":49.912,"price_display":"49.91","price_state":"stated","total_value":2351504.056,"total_display":"2,351,504.06","total_whole":"2,351,504","shares_owned_after":3402551.0,"shares_owned_after_display":"3,402,551","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-08","filed_date":"2020-09-09","scope":"insider"},{"id":2611733,"accession":"0001104659-20-103551","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-103551","line_url":"/filing/0001104659-20-103551#line-1","is_derivative":false,"issuer_cik":"0001425738","issuer_name":"IGM Biosciences, Inc.","issuer_ticker":"IGMS","issuer_name_source":null,"issuer_url":"/issuer/0001425738","owner_cik":null,"owner_name":"Green Jeremy; Redmile Group, LLC","owner_display_name":"Green Jeremy","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":74433.0,"shares_display":"74,433","price_per_share":50.2759,"price_display":"50.28","price_state":"stated","total_value":3742186.0647,"total_display":"3,742,186.06","total_whole":"3,742,186","shares_owned_after":3355438.0,"shares_owned_after_display":"3,355,438","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-04","filed_date":"2020-09-09","scope":"insider"}],"collapsed":true,"next_cursor":"2020-09-04|2611733","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0002058707","name":"Attovia Therapeutics, Inc.","url":"/issuer/0002058707","role":"Ten percent owner","n_filings":1,"first_seen":"2026-08-07","last_seen":"2026-08-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001771910","name":"ADC Therapeutics SA","url":"/issuer/0001771910","role":"Ten percent owner","n_filings":4,"first_seen":"2024-07-03","last_seen":"2026-04-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001434316","name":"FATE THERAPEUTICS INC","url":"/issuer/0001434316","role":"Director, Ten percent owner","n_filings":8,"first_seen":"2018-09-27","last_seen":"2024-12-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001680367","name":"Shattuck Labs, Inc.","url":"/issuer/0001680367","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2020-10-15","last_seen":"2024-12-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001672688","name":"Absci Corp","url":"/issuer/0001672688","role":"Director","n_filings":2,"first_seen":"2021-07-28","last_seen":"2024-03-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001769804","name":"Augmedix, Inc.","url":"/issuer/0001769804","role":"Director, Ten percent owner","n_filings":4,"first_seen":"2020-10-07","last_seen":"2023-11-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001496323","name":"IGM Biosciences, Inc.","url":"/issuer/0001496323","role":"Director, Ten percent owner","n_filings":3,"first_seen":"2020-09-03","last_seen":"2023-07-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001937653","name":"Zymeworks Inc.","url":"/issuer/0001937653","role":"Ten percent owner","n_filings":1,"first_seen":"2022-10-18","last_seen":"2022-10-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001689375","name":"Entrada Therapeutics, Inc.","url":"/issuer/0001689375","role":"Ten percent owner","n_filings":1,"first_seen":"2021-11-04","last_seen":"2021-11-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001832038","name":"Adagio Therapeutics, Inc.","url":"/issuer/0001832038","role":"Ten percent owner","n_filings":1,"first_seen":"2021-08-12","last_seen":"2021-08-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001840574","name":"Verve Therapeutics, Inc.","url":"/issuer/0001840574","role":"Ten percent owner","n_filings":1,"first_seen":"2021-06-23","last_seen":"2021-06-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001781983","name":"Aprea Therapeutics, Inc.","url":"/issuer/0001781983","role":"Ten percent owner","n_filings":2,"first_seen":"2019-10-08","last_seen":"2021-02-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001404644","name":"Neoleukin Therapeutics, Inc.","url":"/issuer/0001404644","role":"Ten percent owner","n_filings":1,"first_seen":"2020-04-06","last_seen":"2020-04-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001346302","name":"XERIS PHARMACEUTICALS INC","url":"/issuer/0001346302","role":"Ten percent owner","n_filings":2,"first_seen":"2018-06-27","last_seen":"2019-02-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001100412","name":"ARRAY BIOPHARMA INC","url":"/issuer/0001100412","role":"Ten percent owner","n_filings":11,"first_seen":"2015-08-10","last_seen":"2016-09-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001556263","name":"Syros Pharmaceuticals, Inc.","url":"/issuer/0001556263","role":"Ten percent owner","n_filings":1,"first_seen":"2016-07-07","last_seen":"2016-07-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001178879","name":"AMICUS THERAPEUTICS INC","url":"/issuer/0001178879","role":"Ten percent owner","n_filings":1,"first_seen":"2016-06-13","last_seen":"2016-06-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001650527","retrieved_at":"2026-08-27T15:54:12+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}